leaks
RCEP - trade in services chapter: Australian proposal re-scheduling value added elements (July 2015)
This 1 page submission dated 31 July 2015.
This 1 page submission dated 5 August 2015.
Minutes of services chapter negotiations at the 9th RCEP negotiating round (August 2015)
ASEAN versus other RCEP country positions on value-add elements in RCEP services chapter
RCEP draft e-commerce chapter terms of reference
The annexes would restrict the job-stimulating localization requirements; restrict how governments and professional associations regulate market access; affect notably the global Internet community of users and innovators.
bilaterals.org has received four impact studies concerning the EU-West Africa EPA and requested Jacques Berthelot to provide a comment on them.
As welcome as the leak is, it doesn’t fix these systemic flaws in the process of negotiating trade agreements such as TTIP and the TPP.
Greenpeace says internal documents show US attempts to lower or circumvent EU protection for environment and public health.
As published by KEI
As leaked on RCEP Legal
Top national politicians must visit a special room in Brussels to read key TTIP documents.
As leaked on RCEP Legal
As leaked by KEI on 4 August 2015
Knowledge Ecology International released text from three sections of the 95-page secret negotiating text on the Intellectual Property Chapter being used in the Trans-Pacific Partnership Agreement trade negotiations
As published by KEI
As published by KEI
On 2 July, WikiLeaks publshed four more chapters from the secret ongoing TiSA (Trade in Services Agremeent) negotiations, ahead of the next negotiating round on Monday: Electronic Commerce, Telecommunications Services, Financial Services and Maritime Transport Services.
WikiLeaks has released a modern journalistic holy grail, the secret Core Text for the largest ’trade deal’ in history, the Trade In Services Agreement, one week before the next TiSA negotiating round
A recent draft of the Trans-Pacific Partnership free-trade deal would give US pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in US law.
